Remarkably, PD-1cKO mice could control tumors as large as 1,500 mm3, and after initial tumor growth, inhibition or complete responses were observed correlating with the progressive deletion of PD-1 expression on CD4 and CD8 T cells. The gene discussed is CD8A; the disease is neoplasm.